Almost a quarter of a million young people have received their first dose of the MenB (meningococcal B) vaccine, according to figures published today by NHS England. Since the vaccination programme started on July 20, 2026, a total of 246,089 doses were administered as of August 31, 2026.
The NHS is urging young people to get a vital second dose for full protection before university courses commence later this month. Two doses of the vaccine, given at least 28 days apart, are required for full shielding against the infection.
Dr Amanda Doyle, NHS National Director for Primary Care and Community Services, highlighted that freshers' weeks and moving into student accommodation can significantly increase the risk of exposure to MenB. Students in their first year of university have a risk of infection that is approximately seven times higher than young people of a similar age who do not attend university.
MenB infection can lead to serious, life-threatening conditions such as inflammation of the brain lining and sepsis. These can result in life-changing disabilities, including amputations, hearing loss, and brain damage, and can sometimes be fatal.
The bacteria causing MenB disease can spread through close contact, such as kissing, sharing drinks or vapes, or prolonged close contact like living in the same home. Eligible individuals can book appointments online via the NHS National Booking Service or contact a participating community pharmacy.